The Patent Finder

Parion Sciences, Inc.

19 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Oct 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 2 to 7, 2027 · next Jan 2
  • 1 fee due Feb 11, 2027
    The maintenance fee for Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds (US 9,102,633) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,987,443Inhaled hypertonic saline delivered by a heated nasal cannula
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,408,988Inhaled hypertonic saline delivered by a heated nasal cannula
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,778,383Methods of treatment
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,945,605Aerosol Delivery Systems, Compositions and Methods
In force
 · Medium confidence
In forceMedium confidence
US 8,669,2623,5-Diamino-6-Chloro-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-Pentahydroxyhexyl)AMINO)ETHOXY)PHENYL)BUTYL) CARBAMIMIDOYL)PYRAZINE-2-Carboxamide
In force
 · High confidence
In forceHigh confidence
US 10,752,5973,5-Diamino-6-Chloro-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-Pentahydroxyhexyl)AMINO)ETHOXY)PHENYL)BUTYL) CARBAMIMIDOYL)PYRAZINE-2-Carboxamide
In force
 · Medium confidence
In forceMedium confidence
US 9,072,738Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,655,896Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,159,672Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,578,0423,5-Diamino-6-Chloro-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-Pentahydroxyhexyl)AMINO)ETHOXY)PHENYL)BUTYL)CARBAMIMIDOYL)PYRAZINE-2-Carboxamide
In force
 · High confidence
In forceHigh confidence
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
Also on record, not counted in the 19: 49 lapsed for an unpaid fee · 15 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 6 abandoned · 20 no status recorded

Showing 1 to 10 of 28, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/832,906Bicyclic-Substituted Epithelial Sodium Channel Blocking CompoundsJan 25, 2023Pending
18/832,903Biphenyl-Substituted Epithelial Sodium Channel Blocking CompoundsJan 25, 2023Pending
16/359,953Mar 20, 2019No status recorded
16/352,5483,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- Carboxamide CompoundsMar 13, 2019Abandoned
16/181,230Sodium Channel BlockersNov 5, 2018Abandoned
16/110,878Chloro-Pyrazine Carboxamide Derivatives with Epithelial Sodium Channel Blocking ActivityAug 23, 2018Abandoned
15/832,939Dec 6, 2017No status recorded
15/485,361Apr 12, 2017No status recorded
14/755,531Jun 30, 2015No status recorded
14/727,189Sodium Channel BlockersJun 1, 2015Abandoned
10 of 28 applications shown.
Pro members see all 28 published applications.
Pro members: see all 28 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited